CRA was retained by the Plaintiff in a trade secrets litigation. CRA’s expert evaluated possible settlement options related to an alleged theft of trade secrets. The team calculated the expected present value (EPV) for the upfront and development milestones of the asset. The EPV model was used to aid counsel in settlement discussions.
Navigating payer challenges in rare disease
Navigating payer challenges for rare disease treatments requires innovative approaches to evidence generation and pricing strategies. Our Life Sciences...